NASDAQ NMS - GLOBAL MARKET · JBIO
+0.52% · +$0.1100 · Vol 571.8K
Market closed · last close 4:00 PM ET · price as of 16:37:07 ET
Jade Biosciences Inc

Jade Biosciences Inc

Biotechnology
$21.34
Card
Relationship Map

Veridion Score

BETAHIGH CONF · 6/6 factorsMethodology
JBIO
Jade Biosciences Inc
Fri Aug 21 · last completed session · Markets closed · resumes Mon 9:30 ET
SELL BIAS

Composite intelligence score across six company factor categories. Missing inputs are excluded from the active factor subset.

39/ 100
Veridion Score
SELL BIAS · HIGH confidence
Sovereign · $25/mo
See why this score moved.
  • · Factor breakdown with raw signals
  • · Day-over-day delta + driver
  • · Factor coverage readout
  • · Valuation · hype · market flow
  • · Pro Chart event markers
  • · Score history + alerts
Start Sovereign · $25/mo →
Cancel anytime · or Reserve · $79/mo
Confidence: HIGH · 6/6 factors with data · Fri Aug 21 · last completed session · Markets closed · resumes Mon 9:30 ET
Share on X →
Veridion Score History · 90D
Loading score history
AI Analysis
Sovereign

Why is JBIO moving today?

Sovereign unlock connects news, insider activity, analyst moves, and live price action.
Loading JBIO catalysts
About Jade Biosciences Inc
PHARMACEUTICAL PREPARATIONS
Listed since
2025
Employees
55
Country
US

Jade Biosciences Inc is a clinical-stage biotechnology company focused on developing therapies for autoimmune diseases. Its flagship candidate, JADE101, targets the cytokine APRIL and is in a Phase 1 clinical trial for the treatment of immunoglobulin A nephropathy. The company's pipeline also includes JADE201, an afucosylated anti-BAFF-R monoclonal antibody, and JADE301, an antibody candidate in preclinical development.

Company website →
Key statistics

Reported fields plus Veridion-computed history. Unsourced tiles are omitted.

Open
$21.45
Day high
$22.12
Day low
$21.13
Previous close
$21.23
52W high
$26.85
-20.52% from high
52W low
$6.95
72% of range
Market cap
$1.4B
EPS
$-1.9200
Beta
1.00
Shares out
63.6M
Volume
571.8K
0.66× rel vol
Avg volume
871.2K
VWAP
$21.51
Price history computed in-house
1W
-9.00%
1M
+6.27%
3M
-1.70%
1Y
+159.30%
YTD
+38.30%
SMA 50 $20.80 · above
SMA 200 $17.46 · above
52W position 72%

JBIO overview

Veridion Score
39
Registered · 2026-08-21
6 of 6 factors measured
Latest receipt rows
0
No recent disclosure on file.
13F holders
None on file

Related filings and maps

Relationship mapTrace receipt-backed holders and filings around JBIO.Congress trackerSearch the public STOCK Act disclosure ledger.MethodologyReview score inputs, coverage rules, and limitations.
Loading financial statements
Loading JBIO Form 4 filings
Public disclosures

Congress activity in JBIO

Congress trackerOpen ticker disclosure ledger →

No receipt-qualified Congressional disclosure is present for JBIO in the cached public ledger.

Federal contracts

JBIO contract awards, year to date.

Public federal awards linked to this ticker.

Not disclosed
Refresh interval: 12hSource: Federal contract awards
No federal contracts on file for JBIO in this window.
Lobbying spend

JBIO lobbying filings, year to date.

Registered lobbying filings matched to Jade Biosciences Inc.

Not disclosed
Refresh interval: 12hSource: LDA disclosure filings
No lobbying filings on file for JBIO in this window.
Loading news for JBIO
Analyst ratings
Sovereign unlock shows live analyst consensus for JBIO.
Options
Sovereign unlock shows live options positioning for JBIO.
Weekly Veridion brief

Rating changes, public disclosure activity, methodology notes, and product updates. One email per week. No advertising list resale.